OOO Medconsult

Co-owners (according to the Unified State Register of Legal Entities as of September 5, 2009): Palomino Assets registered in the British Virgin Islands (79.6%), Evgeny Sporyshev and Anastasia Efimova (9.95% each) – through Perspektiva LLC, Viktor Krutikov (0.03%), Natalya Rodina (0.01%) – directly. Financial indicators (2009): revenue – 4.2 million rubles, net loss – 5.1 million rubles.

The Medconsult company of the Chairman of the Board of Directors of the Centrocredit Bank, Sergei Eremin, is starting construction of a nuclear medicine center worth $20 million.

Medconsult will build a nuclear medicine center on the basis of the Russian Cardiology Scientific and Production Complex of the Ministry of Health and Social Development, a representative of Medconsult said. According to him, the cost of the project is about $20 million, and the main investor of the project is Eremin. A representative of Sberbank confirmed the information about the project: the bank will provide Medconsult with a loan secured by property. He did not name the loan amount.

In Russia, cancer is most often detected at stages three and four, while positron diagnostics allows for the detection of this disease at stages one and two and precise planning of radiation therapy, which should lead to a reduction in the incidence and mortality rates of the country's population, Medconsult reported. According to the Ministry of Health and Social Development, malignant neoplasms were the second most common cause of death in 2010.

The PET-CT (positron emission tomograph combined with a computer tomograph) complex based at the cardiology complex of the Ministry of Health and Social Development will include, among other things, an accelerator that will allow the synthesis of radiopharmaceuticals on site: radiopharmaceuticals contain ultra-short-lived isotopes, the half-life of which is two hours - because of this, they cannot be transported, and the synthesis period of 1 curie of such isotopes (which is enough to serve 45-50 patients) is two hours. That is, the production volume of one cyclotron involved in the project is capable of providing radiopharmaceuticals to all of Moscow, the report says.

$20 million against cancer